NanoViricides
NNVC
58 hedge funds and large institutions have $13.1M invested in NanoViricides in 2015 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 16 increasing their positions, 15 reducing their positions, and 2 closing their positions.
740% more call options, than puts
Call options by funds: $42K | Put options by funds: $5K
200% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 2
7% more funds holding
Funds holding: 54 → 58 (+4)
7% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 15
0% less ownership
Funds ownership: 0.48% → 0.48% (-0%)
15% less capital invested
Capital invested by funds: $15.3M → $13.1M (-$2.25M)
Top Buyers
Top Sellers
| 1 |
VKH
Virtu KCG Holdings
New York
|
-$433K |
| 2 |
Goldman Sachs
New York
|
-$203K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$119K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$92.8K |
| 5 |
Morgan Stanley
New York
|
-$80K |
NNVC Hedge Fund Activity: Q1 2015 in Review
58 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in NanoViricides (NNVC) for Q1 2015, worth a combined $13.1M — down 15% from $15.3M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new NNVC positions and 2 closed out — a net gain of 4 holders — while 16 added to existing stakes and 15 trimmed.
The largest buyer was Colony Group, opening a new position worth an estimated $229K. The largest seller was Virtu KCG Holdings, cutting an estimated $433K.
- 58 institutional investors held NanoViricides (NNVC) as of Q1 2015, up from 54 in Q4 2014.
- Funds reported $13.1M of NanoViricides stock for Q1 2015, down 15% quarter-over-quarter.
- 6 funds opened new NanoViricides positions in Q1 2015 and 2 closed out, a net change of +4 holders.
- The largest NanoViricides buyer in Q1 2015 was Colony Group, an estimated $229K added.
- The largest NanoViricides seller in Q1 2015 was Virtu KCG Holdings, an estimated $433K sold.
Based on aggregated 13F filings for Q1 2015.